Abstract

WIN Symposium 2022 - Abstract Poster Presentations.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract 3266: Classical chemotherapy modulates cytokine secretion in the MSS CRC immune microenvironment and enhances T cell killing
... Kelsey E Huntington
Cancer Research | VOL. 83
, et. al. ... Kelsey E Huntington
04 Apr 2023
Identification of microsatellite instability and immune-related prognostic biomarkers in colon adenocarcinoma.
Desi Shang ... Ziquan Sun
Frontiers in immunology | VOL. 13
Desi Shang, et. al.Desi Shang ... Ziquan Sun
07 Oct 2022
Immune checkpoint inhibitor response in mismatch repair-deficient colorectal cancer and other solid tumors: is it truly disease-agnostic?
Ibrahim Halil Sahin
Colorectal Cancer | VOL. 9
Ibrahim Halil SahinIbrahim Halil Sahin
19 Oct 2020
172 Cancer immunotherapy response monitoring with whole blood immuno-transcriptomic profiling
Sylvain Monnier-Benoit ... Sandra Van Wilpe
Journal for ImmunoTherapy of Cancer | VOL. 11
Sylvain Monnier-Benoit, et. al.Sylvain Monnier-Benoit ... Sandra Van Wilpe
01 Nov 2023
View more papers

More From: Journal of immunotherapy and precision oncology

Paper Title
Journal
Date
Author
Abstracts Presented at the 2024 Win Symposium in Partnership with Burjeel Holdings: March 1–2 Abu Dhabi, United Arab Emirates
-
Journal of Immunotherapy and Precision Oncology | VOL. -
--
17 May 2024
Decentralized Clinical Trials in Early Drug Development—A Framework Proposal
Diogo J Silva ... Jordi Rodon
Journal of Immunotherapy and Precision Oncology | VOL. -
Diogo J Silva, et. al.Diogo J Silva ... Jordi Rodon
07 May 2024
Management of Hepatitis B Virus and Hepatitis C Virus Infections in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
Vincent Mallet ... Harrys A Torres
Journal of immunotherapy and precision oncology | VOL. 7
Vincent Mallet, et. al.Vincent Mallet ... Harrys A Torres
01 May 2024
Phase Ib/II Study of Lacnotuzumab in Combination with Spartalizumab in Patients with Advanced Malignancies.
Shubham Pant ... Yali Yang
Journal of immunotherapy and precision oncology | VOL. 7
Shubham Pant, et. al.Shubham Pant ... Yali Yang
01 May 2024
View more papers